MARIA SMITH: Open Payments
NPI 1972804474 · CANTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 76 payments from 14 companies in 2025. Trend: 2023 $991 · 2024 $1,559 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $281 |
| Vanda Pharmaceuticals Inc. | 8 | $224 |
| Axsome Therapeutics, Inc. | 9 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $169 |
| Corium, LLC | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Tris Pharma Inc | 5 | $91 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
Products named: VRAYLAR, FANAPT, Auvelity, TRINTELLIX, REXULTI, Azstarys, Dyanavel XR, Jornay PM.
Industry payments across MS — which companies pay providers there.
